Canada markets closed

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
50.91-0.17 (-0.33%)
At close: 04:03PM EST
50.63 -0.28 (-0.55%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close51.08
Open50.56
Bid50.63 x 800
Ask50.91 x 4000
Day's Range50.48 - 51.33
52 Week Range41.45 - 61.71
Volume15,858,877
Avg. Volume20,140,077
Market Cap285.774B
Beta (5Y Monthly)0.64
PE Ratio (TTM)9.62
EPS (TTM)5.29
Earnings DateFeb 06, 2023 - Feb 10, 2023
Forward Dividend & Yield1.60 (3.23%)
Ex-Dividend DateNov 03, 2022
1y Target Est54.78
  • Motley Fool

    Why Shares of Prometheus Biosciences Slumped This Week

    Shares of Prometheus Biosciences (NASDAQ: RXDX) were down more than 12% this week as of Friday morning, according to data from S&P Global Intelligence. The clinical-stage biotech company specializes in immunotherapies with a focus on inflammatory bowel disease (IBD). Prometheus' lead therapy in its pipeline is IBD drug PRA023.

  • Zacks

    Roivant (ROIV), Pfizer Form Vant for Inflammatory Disease Drug

    Roivant Sciences (ROIV), Pfizer's (PFE) new Vant company will take care of funding the global development of RVT-3101 in inflammatory and fibrotic diseases.

  • Zacks

    Valneva (VALN) Up on 6-Month Lyme Disease Jab Persistence Data

    Persistence data from a mid-stage study showed that Valneva's (VALN) Lyme disease vaccine elicited antibody levels which remained above baseline six months after completing dose administration in children and adults.